At this year's APIC annual meeting, B. Braun Medical Inc. will display a range of safety-engineered devices designed to advance protection from infection in the healthcare setting for both patients and healthcare workers.
The companys new Introcan Safety® 3 Closed IV Catheter will be in the spotlight, directly addressing issues pertaining to exposure to bloodborne pathogens and catheter-related complications. Like B. Brauns existing Introcan Safety IV Catheter, the next generation Introcan Safety 3 includes passive safety protection from needlestick injuries, with the addition of an innovative multi-access blood control septum to aid in the prevention of blood exposure each time the device is accessed. An integrated stabilization platform is designed to improve catheter stability and minimize movement in the vein, which could help reduce catheter-related complications. Introcan Safety 3 Closed IV Catheter will be available for widespread distribution in July 2012.
Other safety innovations to be displayed include the CARESITE® needleless connector and ULTRAPORT zerO 4-way stopcock, both designed to reduce potential for contamination, improve patient care and increase clinician convenience. The broad line of B. Braun peripheral IV catheters, infusion systems, needleless connectors, stopcocks, and accessory kits that focus on safety in the healthcare setting will be demonstrated at Booth 501. Â
B. Braun is committed to providing products that address the critical issues of infection prevention and healthcare worker and patient safety. Our new Introcan Safety 3 Closed IV Catheter is the latest example of B. Brauns continuous efforts to expand our product offering with designs intended to protect both clinicians and patients from healthcare acquired infections, says Tom Sutton, B. Brauns vice president of marketing for vascular access and IV systems. Sharing our knowledge and expertise of products and best practice is the most important thing we can do at APIC for clinicians, infection control professionals and administrators. Â
B. Braun is hosting two Satellite Education symposia during APIC 2012 that focus on increased infection control and safety in the healthcare setting. On Monday, June 4, 2012 from 6 a.m. to 7:30 a.m. the subject of Intraoperative Infection Control: A Paradigm Shift will be presented by Dr. Randy W. Loftus, MD, assistant professor of anesthesiology at Dartmouth Hitchcock Medical Center and Dr. Matthew D. Koff, MD, MS, assistant professor of anesthesiology at Dartmouth Hitchcock Medical Center, at the San Antonio Convention Center, Room 006 A & B. Â
Lynn Hadaway, M.Ed, RN, BC, CRNI will be featured in a symposium titled Mucocutaneous Blood Exposure and Peripheral Catheters Acknowledging the Risk, Documenting Occurrences on Wednesday, June 6, 2012 from 6 a.m. to 7:30 a.m. at the San Antonio Convention Center, Room 008. Hadaway, the president of Lynn Hadaway Associate, Inc., and more than 35 years of experience in infusion nursing and adult education will be followed by a presentation on new product technology by B. Brauns Tom Sutton. A continental breakfast will be served to attendees of both symposia. Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.